| Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors AI Idris, RJ van't Hof, IR Greig, SA Ridge, D Baker, RA Ross, SH Ralston Nature medicine 11 (7), 774-779, 2005 | 457 | 2005 |
| Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro AI Idris, J Rojas, IR Greig, RJ van’t Hof, SH Ralston Calcified tissue international 82, 191-201, 2008 | 267 | 2008 |
| Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells AI Idris, A Sophocleous, E Landao-Bassonga, M Canals, G Milligan, ... Cell Metabolism 10 (2), 139-147, 2009 | 197 | 2009 |
| Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor AI Idris, A Sophocleous, E Landao-Bassonga, RJ Van't Hof, SH Ralston Endocrinology 149 (11), 5619-5626, 2008 | 174 | 2008 |
| The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo AI Idris, E Landao-Bassonga, SH Ralston Bone 46 (4), 1089-1099, 2010 | 127 | 2010 |
| The type 2 cannabinoid receptor regulates bone mass and ovariectomy-induced bone loss by affecting osteoblast differentiation and bone formation A Sophocleous, E Landao-Bassonga, RJ van ‘t Hof, AI Idris, SH Ralston Endocrinology 152 (6), 2141-2149, 2011 | 117 | 2011 |
| Pharmacologic inhibitors of IκB kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivo AI Idris, H Libouban, H Nyangoga, E Landao-Bassonga, D Chappard, ... Molecular cancer therapeutics 8 (8), 2339-2347, 2009 | 114 | 2009 |
| β2-Adrenoreceptor ligands regulate osteoclast differentiation in vitro by direct and indirect mechanisms SJ Aitken, E Landao-Bassonga, SH Ralston, AI Idris Archives of biochemistry and biophysics 482 (1-2), 96-103, 2009 | 111 | 2009 |
| Rodent models of osteoporosis A Sophocleous, AI Idris BoneKEy reports 3, 2014 | 101 | 2014 |
| Role of cannabinoids in the regulation of bone remodeling AI Idris, SH Ralston Frontiers in endocrinology 3, 136, 2012 | 94 | 2012 |
| Ovariectomy/orchidectomy in rodents AI Idris Bone research protocols, 545-551, 2012 | 92 | 2012 |
| Cannabinoids and bone: friend or foe? AI Idris, SH Ralston Calcified tissue international 87, 285-297, 2010 | 90 | 2010 |
| A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivo A Hughes, MJ Rogers, AI Idris, JC Crockett Calcified tissue international 81, 403-413, 2007 | 82 | 2007 |
| Small molecule inhibitors of IκB kinase signaling inhibit osteoclast formation in vitro and prevent ovariectomy‐induced bone loss in vivo AI Idris, M Krishnan, P Simic, E Landao‐Bassonga, P Mollat, S Vukicevic, ... The FASEB Journal 24 (11), 4545-4555, 2010 | 61 | 2010 |
| Hydrogen sulphide‐releasing diclofenac derivatives inhibit breast cancer‐induced osteoclastogenesis in vitro and prevent osteolysis ex vivo J Frantzias, JG Logan, P Mollat, A Sparatore, P Del Soldato, SH Ralston, ... British journal of pharmacology 165 (6), 1914-1925, 2012 | 52 | 2012 |
| Combined deficiency of the Cnr1 and Cnr2 receptors protects against age‐related bone loss by osteoclast inhibition A Sophocleous, S Marino, D Kabir, SH Ralston, AI Idris Aging Cell 16 (5), 1051-1061, 2017 | 47 | 2017 |
| Cannabinoid receptors as target for treatment of osteoporosis: a tale of two therapies A I Idris Current neuropharmacology 8 (3), 243-253, 2010 | 45 | 2010 |
| Emerging therapeutic targets in cancer induced bone disease: a focus on the peripheral type 2 cannabinoid receptor S Marino, AI Idris Pharmacological Research 119, 391-403, 2017 | 39 | 2017 |
| Bone cell-autonomous contribution of type 2 cannabinoid receptor to breast cancer-induced osteolysis A Sophocleous, S Marino, JG Logan, P Mollat, SH Ralston, AI Idris Journal of Biological Chemistry 290 (36), 22049-22060, 2015 | 37 | 2015 |
| Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice S Marino, D de Ridder, RT Bishop, N Renema, M Ponzetti, ... EBioMedicine 44, 452-466, 2019 | 34 | 2019 |
Antonia SophocleousEuropean University Cyprus在 euc.ac.cy 的电子邮件经过验证
